Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-76.73%
operating margin TTM
-39.04%
revenue TTM
13.29 Million
revenue per share TTM
0.25$
valuation ratios | |
|---|---|
| pe ratio | -0.78 |
| peg ratio | -0.32 |
| price to book ratio | 0.38 |
| price to sales ratio | 0.60 |
| enterprise value multiple | -7.46 |
| price fair value | 0.38 |
profitability ratios | |
|---|---|
| gross profit margin | 43.75% |
| operating profit margin | -39.04% |
| pretax profit margin | -28.54% |
| net profit margin | -76.73% |
| return on assets | -33.19% |
| return on equity | -43.52% |
| return on capital employed | -23.07% |
liquidity ratio | |
|---|---|
| current ratio | 2.84 |
| quick ratio | 2.50 |
| cash ratio | 2.16 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 134.96 |
| operating cycle | 192.20 |
| days of payables outstanding | 32.95 |
| cash conversion cycle | 159.25 |
| receivables turnover | 6.38 |
| payables turnover | 11.08 |
| inventory turnover | 2.70 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.05 |
| debt equity ratio | 0.07 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.06 |
| interest coverage | -54.45 |
| cash flow to debt ratio | -5.10 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.31 |
| cash per share | 0.70 |
| operating cash flow per share | -0.29 |
| free cash flow operating cash flow ratio | 1.07 |
| cash flow coverage ratios | -5.10 |
| short term coverage ratios | -209.88 |
| capital expenditure coverage ratio | -14.92 |
Frequently Asked Questions
When was the last time Enzo Biochem, Inc. (NYSE:ENZ) reported earnings?
Enzo Biochem, Inc. (ENZ) published its most recent earnings results on 17-03-2025.
What is Enzo Biochem, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Enzo Biochem, Inc. (NYSE:ENZ)'s trailing twelve months ROE is -43.52%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Enzo Biochem, Inc. (ENZ) currently has a ROA of -33.19%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ENZ's net profit margin stand at?
ENZ reported a profit margin of -76.73% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ENZ's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.84 in the most recent quarter. The quick ratio stood at 2.50, with a Debt/Eq ratio of 0.07.